Impact of sex and myocardial function on association of obesity with mortality in Asian patients with acute heart failure: a retrospective analysis from the STRATS-AHF registry

Chan Soon Park, Jun-Bean Park, Jin Joo Park, Jae-Hyeong Park, Goo-Yeong Cho, Chan Soon Park, Jun-Bean Park, Jin Joo Park, Jae-Hyeong Park, Goo-Yeong Cho

Abstract

Objectives: Impact of sex and myocardial function on the obesity paradox in heart failure (HF) is unknown. We explored whether sex, myocardial function, and left ventricular (LV) geometry explains the protective association of body mass index (BMI) with mortality, and investigated whether metabolic health status affects this association.

Design: A multicentre cohort study with patients with acute HF admitted from January 2009 to December 2016 with a median follow-up of 33.7 months.

Setting: Three tertiary hospitals.

Participants: A total of 2021 overweight-to-obese (OW) and 1543 normal-weight (NW) patients with acute HF.

Measurements: The primary outcome was all-cause mortality. Patients were categorised as either OW (BMI≥23kg/m2) or NW (BMI<23kg/m2). BMI was used as both categorical and continuous variables. Clinical, laboratory and echocardiographic measures, including LV global longitudinal strain (LV-GLS), LV-ejection fraction, LV geometry, were obtained.

Results: During the follow-up period, 1392 patients died (685 OW and 707 NW). BMI was significantly associated with mortality in univariate (HR=0.929 per kg/m2, p<0.001) and multivariate analyses (HR=0.954 per kg/m2, p<0.001). In multivariable fractional polynomials, higher BMIs were associated with lower mortality overall and in subgroups by sex, LV-GLS and LV geometry, with a steeper association in men (p-interaction <0.001). In women, there were significant interactions of BMI with LV-GLS (p-interaction=0.044) and age (p-interaction=0.040) for mortality; the protective association of BMI with mortality was confined to subgroups with high LV-GLS (>10.1%) or elderly patients (≥75 years). In men, this association was found in all subgroups without significant interaction. Metabolically healthy obese patients had better survival than metabolically unhealthy obese patients (log-rank p<0.001).

Conclusions: In women, a significant interaction was observed between BMI and age or LV-GLS in association with mortality, suggesting that sex, ageing and myocardial dysfunction can affect the magnitude of the obesity paradox in HF. Metabolic health status provides prognostic information beyond obesity status.

Trial registration number: Registry: ClinicalTrials.gov Number: NCT03513653 (https://ichgcp.net/clinical-trials-registry/NCT03513653).

Keywords: Heart failure; left ventricular geometry; metabolic health status; myocardial function; obesity paradox; sex-related difference.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Kaplan-Meier curves demonstrating the mortality risk by sex (A), LV-GLS (B) or LV geometry (C) in two subgroups stratified by obesity status. GLS, global longitudinal strain; LV, left ventricle; NW, normal weight; OW, overweight-to-obese.
Figure 2
Figure 2
Forest plots of adjusted HRs depicting mortality in four subgroups categorised by BMI and sex (A), LV-GLS (B) or LV geometry (C). HRs were adjusted for the independent variables shown in table 2. BMI, body mass index; GLS, global longitudinal strain; LV, left ventricle; NW, normal weight; OW, overweight-to-obese.
Figure 3
Figure 3
Forest plots of adjusted HRs for the relationship of BMI, per 1 kg/m2 increment as a continuous variable, with all-cause mortality in men (A) and women (B). The HR within each stratum was adjusted for the independent variables shown in table 2. BMI, body mass index; EF, ejection fraction; GLS, global longitudinal strain; LV, left ventricle

References

    1. Kenchaiah S, Evans JC, Levy D, et al. . Obesity and the risk of heart failure. N Engl J Med 2002;347:305–13. 10.1056/NEJMoa020245
    1. Lavie CJ, Sharma A, Alpert MA, et al. . Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis 2016;58:393–400. 10.1016/j.pcad.2015.12.003
    1. Horwich TB, Fonarow GC, Clark AL. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis 2018;61:151–6. 10.1016/j.pcad.2018.05.005
    1. Shah R, Gayat E, Januzzi JL, et al. . Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox. J Am Coll Cardiol 2014;63:778–85. 10.1016/j.jacc.2013.09.072
    1. Vest AR, Wu Y, Hachamovitch R, et al. . The heart failure Overweight/Obesity survival paradox: the missing sex link. JACC Heart Fail 2015;3:917–26. 10.1016/j.jchf.2015.06.009
    1. Padwal R, McAlister FA, McMurray JJV, et al. . The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data. Int J Obes 2014;38:1110–4. 10.1038/ijo.2013.203
    1. Stokke TM, Hasselberg NE, Smedsrud MK, et al. . Geometry as a Confounder when assessing ventricular systolic function: comparison between ejection fraction and strain. J Am Coll Cardiol 2017;70:942–54. 10.1016/j.jacc.2017.06.046
    1. Lavie CJ, Milani RV, Ventura HO, et al. . Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol 2007;100:1460–4. 10.1016/j.amjcard.2007.06.040
    1. Patel DA, Lavie CJ, Artham SM, et al. . Effects of left ventricular geometry and obesity on mortality in women with normal ejection fraction. Am J Cardiol 2014;113:877–80. 10.1016/j.amjcard.2013.11.041
    1. Lavie CJ, Ventura HO. The obesity paradox in heart failure: is it all about fitness, fat, or sex? JACC Heart Fail 2015;3:927–30. 10.1016/j.jchf.2015.07.009
    1. Park JJ, Park J-B, Park J-H, et al. . Global longitudinal strain to predict mortality in patients with Acute Heart Failure. J Am Coll Cardiol 2018;71:1947–57. 10.1016/j.jacc.2018.02.064
    1. Carnethon MR, De Chavez PJD, Biggs ML, et al. . Association of weight status with mortality in adults with incident diabetes. JAMA 2012;308:581–90. 10.1001/jama.2012.9282
    1. Willett WC, Hu FB, Thun M. Overweight, obesity, and all-cause mortality. JAMA 2013;309:1681 10.1001/jama.2013.3075
    1. Choo V. WHO reassesses appropriate body-mass index for Asian populations. Lancet 2002;360:235 10.1016/S0140-6736(02)09512-0
    1. Lang RM, Badano LP, Mor-Avi V, et al. . Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of echocardiography and the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 2015;16:233–71. 10.1093/ehjci/jev014
    1. Lee SE, Lee H-Y, Cho H-J, et al. . Clinical characteristics and outcome of acute heart failure in Korea: results from the Korean acute heart failure registry (KorAHF). Korean Circ J 2017;47:341–53. 10.4070/kcj.2016.0419
    1. Wong CY, O'Moore-Sullivan T, Leano R, et al. . Alterations of left ventricular myocardial characteristics associated with obesity. Circulation 2004;110:3081–7. 10.1161/01.CIR.0000147184.13872.0F
    1. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009;53:1925–32. 10.1016/j.jacc.2008.12.068
    1. Obokata M, Reddy YNV, Pislaru SV, et al. . Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction. Circulation 2017;136:6–19. 10.1161/CIRCULATIONAHA.116.026807
    1. WHO Expert Consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157–63. 10.1016/S0140-6736(03)15268-3
    1. Garcia-Moll X. Obesity and prognosis: time to forget about metabolically healthy obesity. Eur Heart J 2018;39:407–9. 10.1093/eurheartj/ehx535
    1. Mørkedal B, Vatten LJ, Romundstad PR, et al. . Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: Hunt (Nord-Trøndelag health study), Norway. J Am Coll Cardiol 2014;63:1071–8. 10.1016/j.jacc.2013.11.035
    1. Turkbey EB, McClelland RL, Kronmal RA, et al. . The impact of obesity on the left ventricle: the multi-ethnic study of atherosclerosis (MESA). JACC Cardiovasc Imaging 2010;3:266–74. 10.1016/j.jcmg.2009.10.012
    1. Lavie CJ, Milani RV, Ventura HO. Adipose Composition and Heart Failure Prognosis: Paradox or Not? J Am Coll Cardiol 2017;70:2750–1. 10.1016/j.jacc.2017.10.017
    1. Tsujimoto T, Kajio H. Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF. J Am Coll Cardiol 2017;70:2739–49. 10.1016/j.jacc.2017.09.1111
    1. Kennedy AB, Lavie CJ, Blair SN. Fitness or fatness: which is more important? JAMA 2018;319:231–2. 10.1001/jama.2017.21649
    1. Lavie CJ, Ortega FB, Kokkinos P. Impact of physical activity and fitness in metabolically healthy obesity. J Am Coll Cardiol 2018;71:812–3. 10.1016/j.jacc.2017.10.106
    1. McAuley PA, Keteyian SJ, Brawner CA, et al. . Exercise capacity and the obesity paradox in heart failure: the fit (Henry Ford exercise testing) project. Mayo Clin Proc 2018;93:701–8. 10.1016/j.mayocp.2018.01.026
    1. Moholdt T, Lavie CJ, Nauman J. Sustained Physical Activity, Not Weight Loss, Associated With Improved Survival in Coronary Heart Disease. J Am Coll Cardiol 2018;71:1094–101. 10.1016/j.jacc.2018.01.011
    1. Lavie CJ, Laddu D, Arena R, et al. . Healthy weight and obesity prevention: JACC health promotion series. J Am Coll Cardiol 2018;72:1506–31. 10.1016/j.jacc.2018.08.1037
    1. Fletcher GF, Landolfo C, Niebauer J, et al. . Promoting physical activity and exercise: JACC health promotion series. J Am Coll Cardiol 2018;72:1622–39. 10.1016/j.jacc.2018.08.2141

Source: PubMed

3
Abonnieren